Stock CONTRAFECT CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar ContraFect Corp Nasdaq

Equities

US2123262014

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for ContraFect Corp
May. 03 North American Morning Briefing : Apple, Amgen -2- DJ
Apr. 26 North American Morning Briefing : Tech Still in -2- DJ

Chart calendar ContraFect Corp

d1a346c5ded9673e4c992c0dc517a437.P0bEoIISA-Gq8c2wz2dKbMmhWLPIZ_IJhLnawVmpj5o.dBS39MVBZrf9pJf3iDQ6BvvYK-nlMMpgxt7qt2ma__xxc46T7VFFivCXiA~68dc5649036859e5bbf81136e6ecd20b

Upcoming events on ContraFect Corp

2024-08-08 Q2 2024 Earnings Release (Projected)

Past events on ContraFect Corp

2023-11-20 Extraordinary Shareholders Meeting
2023-10-23 09:00 am Extraordinary Shareholders Meeting
2023-09-20 03:30 pm ASM and ESCMID Joint Conference - Poster Number 007
2023-09-20 09:45 am ASM and ESCMID Joint Conference - Methodologies on Clinical Development
2023-09-07 02:15 pm World Anti Microbial Resistance Congress
2023-08-14 08:30 am Q2 2023 Earnings Release
2023-06-21 10:00 am Maxim Group Virtual Healthcare Conference
2023-06-17 11:00 am ASM Microbe Conference - Poster Number:529
2023-06-17 11:00 am ASM Microbe Conference - Poster Number:524
2023-06-16 11:00 am ASM Microbe Conference - Poster Number:487
2023-06-16 11:00 am ASM Microbe Conference - Poster Number:476
2023-05-16 09:00 am Annual General Meeting
2023-05-15 08:00 am Q1 2023 Earnings Release
2023-04-17 06:00 am European Clinical Microbiology & Infectious Diseases Meeting - Abstract ID #05341
2023-04-17 06:00 am European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05336
2023-04-17 06:00 am European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033
2023-04-17 06:00 am European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05345
2023-04-15 03:30 am European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033
2023-03-31 08:30 am Q4 2022 Earnings Release
2023-02-10 09:00 am Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-34,1
-29,9
-13.95%		-47,1
-43,8
-7.57%		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-31,1
-30,2
-2.96%		-27,9
-29,1
4.18%		-34,2
-32,4
-5.73%		-47,3
-44,8
-5.42%		-56,9
-63,4
10.27%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-37,7
-51,5
26.79%		-12,8
-10,1
-26.92%		-28,2
-32,8
14.13%		-20,3
-29,0
30.02%		-65,2
-60,8
-7.16%
Net income
Million USD		Released
Forecast
Spread 		-37,7
-51,5
26.79%		-12,8
-10,1
-26.92%		-28,2
-32,8
14.13%		-20,3
-28,1
27.74%		-65,2
-60,8
-7.16%
EPS
USD		Released
Forecast
Spread 		-400
-542
26.25%		-123
-90,6
-35.98%		-99,2
-122
18.74%		-44,0
-60,8
27.63%		-125
-124
-0.78%
Announcement Date14/03/1918/03/2030/03/2124/03/2231/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-11,7
-11,0
-6.68%		-14,1
-11,3
-24.51%		-16,0
-11,9
-34.28%		-20,0
-14,2
-41.28%		-14,2
-12,6
-12.54%		-6,70
-13,2
49.22%		-8,86
-6,50
-36.28%		-7,98
-6,70
-19.03%		-6,68
-7,10
5.96%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,29
-10,8
51.02%		-4,40
-11,1
60.52%		-20,2
-11,9
-69.39%		-18,1
-14,2
-27.61%		-17,1
-12,6
-35.45%		-9,84
-13,2
25.46%		-1,37
-6,50
78.91%		-7,57
-6,70
-12.96%		-5,36
-7,10
24.52%
Net income
Million USD		Released
Forecast
Spread 		-5,29
-10,8
51.02%		-4,40
-10,5
58.03%		-20,2
-11,9
-69.39%		-18,1
-13,0
-39.32%		-17,1
-10,2
-67.32%		-9,84
-13,2
25.46%		-1,37
-6,50
78.91%		-7,57
-6,70
-12.96%		-5,36
-7,10
24.52%
EPS
USD		Released
Forecast
Spread 		-10,4
-22,4
53.57%		-8,80
-22,4
60.71%		-40,8
-23,8
-71.43%		-36,8
-26,4
-39.39%		-34,4
-18,4
-86.96%		-16,1
-27,2
40.66%		-0,69
-10,8
93.63%		-1,94
-1,81
-7.18%		-0,50
-0,66
24.24%
Announcement Date15/11/2124/03/2216/05/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/23

Upcoming sector events for ContraFect Corp

2024-07-15 01:45 am ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 am BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for ContraFect Corp

2024-05-29 04:01 pm IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 am CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 am EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 05:14 pm ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 am EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 am BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 04:05 pm CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 04:05 pm KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CFRXQ Stock
  4. Stock
  5. Calendar ContraFect Corp